… the results of this study, InO was granted Breakthrough Therapy designation by the US Food
and Drug Administration (FDA) in October 2015, and was approved by the FDA in August …

Defining prognostic variables in T-lymphoblastic lymphoma (T-LL) remains a challenge.
AALL1231 was a COG phase 3 clinical trial for newly diagnosed with T Acute Lymphoblastic …

… Exposures were on 6 and 9 August off a dock on lake A, 12 August at a public beach on
lake B, and 15 August off an island in the river accessed by boat. She had no history of travel …

BACKGROUND: Medication reconciliation has been recognized as an important process in
care transitions to prevent adverse health outcomes. Because older adults have multiple …

Background Obesity affects over one‐third of older adults in the United States. Both aging
and obesity contribute to an increased risk for chronic disease, early mortality, and additional …

Background: Understanding the risk and trends of sports-related concussion among 12
scholastic sports may contribute to concussion detection, treatment, and prevention. Purpose: To …

… After the initial 2 cases were detected in August 2016, we conducted point prevalence surveys
(PPSs) from August 2016 to December 2018 in Chicago short-term acute-care hospitals (…

Background Chronic rhinosinusitis (CRS) in aspirin‐exacerbated respiratory disease (AERD)
represents a recalcitrant form of sinonasal inflammation for which a multidisciplinary …

… We also describe splice variants skipping the AUG-containing exon 2 and failing to produce
any identifiable protein, thereby defining an event that is rate limiting for epitope presentation…

… 14 August and at least 60 600 homes had been impacted to varying degrees. As of 17 August,
… Using observational data, we find that the observed local return time of the 12–14 August …